None
Quote | Axovant Gene Therapies Ltd. (NYSE:AXGT)
Last: | $ |
---|---|
Change Percent: | 1.44% |
Open: | $4.12 |
Close: | $4.23 |
High: | $4.37 |
Low: | $4.0794 |
Volume: | 57,823 |
Last Trade Date Time: | 02/12/2020 04:40:05 pm |
News | Axovant Gene Therapies Ltd. (NYSE:AXGT)
Sio Gene Therapies (SIOX) has dosed the first patient in the high-dose cohort of Phase 1/2 (Stage 1) study evaluating AXO-AAV-GM1 gene therapy for Type I (infantile) and Type II (late infantile and juvenile onset) GM1 gangliosidosis.High-dose cohort is evaluating a dose of 4.5x1013&...
On-track to report t opline r esults from low-dose cohort by end of 2020 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to ra...
Message Board Posts | Axovant Gene Therapies Ltd. (NYSE:AXGT)
Subject | By | Source | When |
---|---|---|---|
AXOVANT ANNOUNCES GLOBAL LICENSING AGREEMENT FOR AXO-AAV-OPMD PROGRAM | georgejjl | investorshub | 06/06/2019 1:32:55 AM |
I cannot believe this "company" is still scamming | BostonSportsNut | investorshub | 05/23/2019 12:20:51 AM |
sitting on a big day here | whosjohngalt | investorshub | 03/11/2019 11:52:08 AM |
closing in on 52 week high | whosjohngalt | investorshub | 03/07/2019 6:34:47 PM |
good volume, good move today. eom | whosjohngalt | investorshub | 03/04/2019 9:39:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Axovant Gene Therapies Ltd. Company Name:
AXGT Stock Symbol:
NYSE Market:
On-track to report t opline r esults from low-dose cohort by end of 2020 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to ra...
A pioneering researcher , Dr. Gao has made foundational contributions to the discovery of novel AAV vectors for gene therapy Dr. Gao recently served as President of the American Society for Gene and Cell Therapy (ASGCT) and has been ranked as one of...
Rebranding to Sio Gene Therapies to reflect an independent company with a scientific strategy focused on disease-modifying and curative genetic medicines Company’s common stock will trade on the NASDAQ under new ticker “SIOX” effective November 13, 2020 ...